Faster healing for
diabetic foot ulcers
An automated light and sound therapy device that integrates into existing clinic workflows — delivering repeatable, standardized treatment in under 20 minutes.
Diabetic foot ulcers are common, costly, and deadly
Current care is effective but labor-heavy. Advanced adjunct therapies often don't fit routine clinic workflows — creating a critical gap in treatment scale.
18.6M
People affected annually
Worldwide
1.6M
New U.S. DFU cases
Per year
$9-13B
Annual economic burden
U.S. incremental cost
24wk
Typical treatment duration
Standard of care
Why DFUs remain hard to treat at scale
Labor-intensive standard care
Debridement, offloading, dressings, infection control — high visit cadence with variable clinician technique.
Bulky adjunct systems
Existing devices require a complex setup that doesn't align with outpatient clinic workflows.
Poor repeatability
Hard to target consistently across different clinicians and visits, limiting treatment efficacy.
High cost barriers
Complex supply chains and expensive consumables limit adoption in routine care settings.
The opportunity
Scalable, repeatable clinic workflows that speed healing and reduce downstream complications — through automated adjunct therapy that fits seamlessly into existing care pathways.
WHAT'S NEEDED
A more effective and automated adjunct DFU therapy that integrates into existing clinical workflows without disruption.
Bridging the gap between clinical efficacy and clinical reality
Designed to bring proven therapeutic modalities into routine outpatient workflows — automatically.
Dual complementary modality
Photobiomodulation (PBM) and focused shockwave therapy (ESWT) delivered in one streamlined procedure.
Automated sound + light therapy for routine DFU care
A point-of-care platform designed to integrate into existing clinical pathways in under 20 minutes per visit.
Standardized targeting
Foot-shaped cradle positions the wound consistently visit-to-visit, independent of operator technique.
AI-automated therapy
Image-based AI targeting of treatment zones enables seamless automation with minimal clinician input.
Lumipulse — first-of-its-kind combination therapy
The first device to combine photobiomodulation therapy and extracorporeal shockwave therapy in a single automated platform — designed specifically for outpatient DFU care.
STEP 01
Position
Place foot into standardized cradle targeting plantar ulcers
Built for routine DFU clinic visits
Fast setup, standardized positioning, automated therapy — designed for throughput.
STEP 01
Couple
Apply disposable coupling pad for acoustic consistency
STEP 01
ESWT
Focused shockwave therapy pulses delivered (~10 min)
STEP 01
PBM
Red + near-infrared light dose administered (~10 min)
STEP 01
Document
Auto-log presets, dose, operator, and timestamp
≤20 min
Add-on to routine visit
Automated
Only setup time from clinic
Standardized
Consistent across operators
Photobiomodulation (PBM)
Red and near-infrared light modulates inflammation and supports cellular energy processes as an adjunct to standard care.
6.72×
Odds ratio for faster ulcer area reduction vs. control
Controlled randomized DFU trials
Focused ESWT (shockwave)
Mechanical stimulus promotes tissue repair signaling, angiogenesis, and remodeling as an adjunct to standard care.
1.57×
Higher complete healing rates vs. the standard of care
Systematic review/meta-analysis across 10 RCTs
CORE THESIS
Combining ESWT + PBM in a single clinic workflow will improve treatment outcomes through complementary mechanisms of action, while automated therapy administration will improve adoption rates across care settings.
Built on proven therapeutic modalities
Both ESWT and PBM have demonstrated clinical benefit in DFU care. Lumisonix combines and automates both in a single device.
Team Member
CTO & Co-Founder
Background and credentials placeholder — to be provided by the team.
Team Member
Clinical Advisor
Background and credentials placeholder — to be provided by the team.
Team Member
Engineering Lead
Background and credentials placeholder — to be provided by the team.
Built by clinicians and engineers
Filip Peters
CEO & Co-Founder
Background and credentials placeholder — to be provided by the team.
Our team combines deep clinical expertise in wound care with medical device engineering and regulatory experience.
Interested in Lumisonix?
Whether you're a clinician, investor, or potential partner, we'd love to hear from you.